This product is a recombinant humanized anti-Respiratory syncytial virus monoclonal antibody. MEDI-493 specifically binds to F glycoprotein associated with RSV and can be potentially used in the diagnosis and treatment of Respiratory syncytial virus infection.
Figure 1 Plaque-reduction assay of neutralization of RSV by MEDI-493.
O ^ RSV Long (A subtype) -f- MEDI-493; A = RSV 18537 (B subtype) H- MEDI-493; = RSV Long -I- RSV intravenous immune globulin (lot 4).
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus
Figure 2 Microneutralization assay of MEDI-493 and RSV in- travenous immune globulin (IVIG) using clinical isolates of RSV.
O = MEDI-493; = RSV IVIG; A ^ no antibody added.
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus
Figure 3 Single-dose serum pharmacokinetics and lung bio-distribution of palivizumab, AFFF and A4b4 in cotton rats.
Antibodies at 3 mg/kg were administered by i.m. injection. Animals were bled retro-orbitally at various times after antibody infusion, and serum human IgG titers were measured by ELISA.
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract
Figure 4 Pharmacokinetics of palivizumab, A4b4, A4b4-F52S (shown as F52S) and 493L1FR-S29R (motavizumab) in cynomolgus monkeys.
A single dose at 30 mg/kg of palivizumab or its variants was administered to cynomolgus monkeys by i.v. injection.
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-009 | Anti-RSV Recombinant Antibody (Palivizumab) | IF, IP, Neut, FuncS, ELISA, FC, WB | IgG1 - kappa |
TAB-709 | Anti-RSV glycoprotein F Recombinant Antibody (Motavizumab) | IF, IP, Neut, FuncS, ELISA, FC, WB | IgG1 - kappa |
MRO-1209LC-S(P) | Anti-HRSV F Recombinant Antibody scFv Fragment (MEDI-493) | ELISA | Humanized antibody |
MRO-1209LC-F(E) | Anti-HRSV F Recombinant Antibody Fab Fragment (MEDI-493) | ELISA | Humanized antibody |
There are currently no Customer reviews or questions for MRO-1209LC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.